Literature DB >> 20339977

Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator.

Atsushi Takahashi1, Tsuyoshi Shiga, Morio Shoda, Kohei Tanizaki, Tetsuyuki Manaka, Koichiro Ejima, Hiroshi Kasanuki, Nobuhisa Hagiwara.   

Abstract

Previous studies indicated that women were less likely to experience ventricular arrhythmia recurrence than men among patients with coronary artery disease and implantable cardioverter defibrillator (ICD). However, it is not clear whether the risk for ventricular tachyarrhythmia is gender-dependent in patients with nonischemic dilated cardiomyopathy. This study included 173 consecutive nonischemic dilated cardiomyopathy patients with a left ventricular ejection fraction of <45% (122 men and 51 women), who received ICD therapy between 1990 and 2008. The average follow-up period was 33 +/- 28 months. There was no significant difference in event-free rates of appropriate ICD therapy between genders for all patients (P = 0.15) and by indication of ICD (primary prevention: P = 0.43, secondary prevention: P = 0.24). There was also no significant difference in event-free rates of electrical storm between genders (P = 0.17). In high-risk patients with nonischemic dilated cardiomyopathy who received ICD, there was no gender difference in the incidence of appropriate ICD therapy or electrical storm.

Entities:  

Mesh:

Year:  2010        PMID: 20339977     DOI: 10.1007/s00380-009-1181-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  15 in total

1.  ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-25       Impact factor: 29.690

2.  Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giuseppe Boriani; Paolo Artale; Mauro Biffi; Cristian Martignani; Lorenzo Frabetti; Cinzia Valzania; Igor Diemberger; Matteo Ziacchi; Matteo Bertini; Claudio Rapezzi; Mario Parlapiano; Angelo Branzi
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

3.  Benefits of the implantable cardioverter-defibrillator.

Authors:  Andrew E Epstein
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

Review 4.  Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.

Authors:  Michael J Yarnoz; Anne B Curtis
Journal:  Cardiol Rev       Date:  2006 Nov-Dec       Impact factor: 2.644

5.  Gender differences in electrophysiologic effects of mental stress and autonomic tone inhibition: a study in health individuals.

Authors:  Per Insulander; Hans Vallin
Journal:  J Cardiovasc Electrophysiol       Date:  2005-01

6.  Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.

Authors:  Wojciech Zareba; Arthur J Moss; W Jackson Hall; David J Wilber; Jeremy N Ruskin; Scott McNitt; Mary Brown; Hongyue Wang
Journal:  J Cardiovasc Electrophysiol       Date:  2005-12

7.  Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms.

Authors:  Chirine Parsai; Robert F Bonvini; Bruno Schnetzler; Henri Sunthorn
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

8.  The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.

Authors:  Henry A Chen; Henry H Hsia; Randall Vagelos; Michael Fowler; Paul Wang; Amin Al-Ahmad
Journal:  Pacing Clin Electrophysiol       Date:  2007-03       Impact factor: 1.976

9.  Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.

Authors:  Andrea M Russo; Jeanne E Poole; Daniel B Mark; Jill Anderson; Anne S Hellkamp; Kerry L Lee; George W Johnson; Michael Domanski; Gust H Bardy
Journal:  J Cardiovasc Electrophysiol       Date:  2008-03-26

10.  Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.

Authors:  Christine M Albert; Rebecca Quigg; Samir Saba; N A Mark Estes; Andi Shaechter; Haris Subacius; Adam Howard; Joseph Levine; Alan Kadish
Journal:  Am Heart J       Date:  2008-08       Impact factor: 4.749

View more
  7 in total

1.  Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects.

Authors:  Tsuyoshi Shiga; Takanori Tanaka; Shin Irie; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

2.  Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy.

Authors:  Hua Xiao; Min Wang; Yimei Du; Jing Yuan; Guanghong Zhao; Danna Tu; Yu-Hua Liao
Journal:  Heart Vessels       Date:  2011-08-04       Impact factor: 2.037

3.  Electrical storm originating from a left ventricular epicardial scar in a patient with completely normal endocardial voltage.

Authors:  Eduardo Back Sternick; Christopher Piorkowski; Gerhard Hindricks; Nikolaos Dagres; Philipp Sommer
Journal:  Heart Vessels       Date:  2011-01-28       Impact factor: 2.037

4.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

5.  Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.

Authors:  Christian Knackstedt; Marlies Arndt; Karl Mischke; Nikolaus Marx; Fred Nieman; Hanns Jürgen Kunert; Patrick Schauerte; Christine Norra
Journal:  Heart Vessels       Date:  2013-06-04       Impact factor: 2.037

6.  Sex Differences in Utilisation and Response to Implantable Device Therapy.

Authors:  Deepika Narasimha; Anne B Curtis
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

7.  ZBTB17 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Authors:  Yu-Min Sun; Jun Wang; Ying-Jia Xu; Xin-Hua Wang; Fang Yuan; Hua Liu; Ruo-Gu Li; Min Zhang; Yan-Jie Li; Hong-Yu Shi; Liang Zhao; Xing-Biao Qiu; Xin-Kai Qu; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-02-14       Impact factor: 1.814

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.